BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Bio-Interaction

Emerson Experts Discuss the Benefits of Digitalization in the Life Sciences Industry

How can digitalization help improve the efficiency and speed of drug development in the life sciences industry? Michalle Adkins: Techn...

February 27, 2023 | Influencers

STADA builds on Movapo heritage to offer Australian Parkinson’s patients new option

Can you explain the details of the new medicine now available on the Pharmaceutical Benefits Scheme for people with Parkinson's disease? Ongentys (opicapo...

February 13, 2023 | News

GenScript is increasing its capacity for producing cGMP sgRNA and non-viral DNA payloads in order to keep project wait times to a minimum.

How is GenScript planning to meet the growing demand for cell and gene therapies in 2023? GenScript is committed to advancing non-viral gene and cell ther...

February 01, 2023 | Influencers

Aptamer Group’s discovery platform is enabling new solutions across the life sciences.

How is success in the discovery of small molecule ligands increased with the Optimer platform? The Optimer platform incorporates three se...

January 04, 2023 | News

Process design and modular facilities to advance sustainability in biomanufacturing

A growing bulk of this demand comes from biologics which have become the mainstay of treatment methods from cancer to autoimmune disorder to viral infectio...

August 15, 2022 | Opinion | By Francis Van Parys, Vice President (Commercial) APAC at Cytiva

" Our partnerships with both NGS & TGS technology giants have facilitated the world’s most comprehensive populations genomics initiative, enabling us to provide cost-effective, high-accuracy sequencing at scale " : Ashish Koshy

What are the major plans in store for G42 Healthcare? Any new segments to be explored? G42 Healthcare is transforming the traditional he...

June 28, 2022 | News

" We are seeing a growing need for contract research organizations (CROs), pharmaceutical companies and regulators in APAC for access to the bioanalysis training needed to conduct drug equivalence tests for the approval of generic drugs " : David Curtin

What are the current opportunities and challenges at Waters ? There is a lot of activity with pharma contract organizations in Asia. F...

June 27, 2022 | Influencers

Technology as an ally to healthcare: How tech solutions can help democratise treatments and relieve the pressure on health systems

Today, every child knows how to run a computer and its capabilities have developed dramatically. In fact, between traditional PCs, laptops, phones, tablets...

February 22, 2022 | Influencers | By Dr. Angelica Kohlmann, Co-founder of Bloom Diagnostics

Thermo Fisher Scientific is responding by increasing capacity and diversifying into new geographies and innovative therapies

1) What strategic changes have you brought about within the business due to COVID-19? Essential to Thermo Fisher Scientific’s ability to support bi...

November 12, 2021 | Influencers

How Covid-19 Became a Catalyst for Tracking Health Data and Digitizing Healthcare

Ever since we began living in organized societies, we have attempted to find better ways to manage our health. As a result, we’ve often appointed a f...

October 15, 2021 | Opinion

In Asia, and across the globe, the medical device and diagnostic market was boosted by the pandemic and some quick solutions were developed.

What strategic changes have you brought about within the business due to COVID-19? Bloom Diagnostics decided to make healthcare more acces...

October 11, 2021 | Opinion

Strengthen mental health services: WHO

“Majority of the people living with mental health problems in the low-and middle-income countries do not get adequate treatment. The ongoing COVID-19...

October 10, 2021 | News

We continue to see expansion across each of our key Optimer application areas, therapeutics, bioprocessing, diagnostics, and research reagents

What strategic changes have you brought about within the business due to COVID-19? The COVID-19 pandemic highlighted a number of issues within the l...

October 06, 2021 | Opinion

We expect more first-in-class and biosimilar drugs to be approved and produced in China

Francis Van Parys is currently responsible for providing transformational technologies in biopharmaceutical research, manufacturing and diagnostics to Cyti...

October 04, 2021 | Influencers

Stay Connected